CBS 2019
CBSMD教育中心
English

Cardio-Oncology

科研文章

荐读文献

ACS Management in a Patient in Need of Noncardiac Surgery Cardiovascular effects of radiation therapy Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review Apixaban to Prevent Venous Thromboembolism in Patients with Cancer Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement Drug-Drug Interactions of Common Cardiac Medications and Chemotherapeutic Agents
|<< 1 2 3 4 >>|

Clinical Trial2018;4.Epub 2018 Aug 29.

JOURNAL:Cardiooncology. Article Link

Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers

Poklepovic A, Qu Y, Dickinson M et al. Keywords: Anthracycline; Biomarker; Cardioprotection; Chemotherapy; Clinical trial; Doxorubicin; Ejection fraction; Strain

FULL TEXT PDF